1. Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials

   • Luigi Mansi

   Book Review 21 June 2022 Pages: 3305 - 3305

2. Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals

   • Lavinia Elena Chiti
   • M. C. Nolff
   • D. Stefanello

   Editorial 05 May 2022 Pages: 3306 - 3308

3. 2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe

   • Richard Graham
   • Ana P. Moreira
   • François Jamar

   Editorial 23 June 2022 Pages: 3309 - 3315

   

4. To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment

   • Murat Tuncel
   • Alexis Vrachimis
   • Luca Giovanella

   Editorial 18 May 2022 Pages: 3316 - 3319

5. Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging

   • Martina Sollini
   • Rodolfo Hurle
   • Massimo Lazzeri

   Editorial 22 March 2022 Pages: 3320 - 3321

6. Total-body [¹⁸F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?

   • Luca Filippi
   • Orazio Schillaci

   Editorial 09 April 2022 Pages: 3322 - 3327

   

7. EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([¹⁷⁷Lu]Lu-PSMA)

   • Stefano Fanti
   • Jolanta Kunikowska
   • Anders Bjartell

   Editorial 14 June 2022 Pages: 3328 - 3329

8. Construction and implementation of regional high-level PET alliance based on international consensus

   • Jianshe Yang
   • Zhongwei Lv

   Letter to the Editor 12 April 2022 Pages: 3330 - 3331

9. [¹⁷⁷Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database

   • Jonathan Vigne
   • Basile Chrétien
   • Charles Dolladille

   Letter to the Editor 06 May 2022 Pages: 3332 - 3333

10. Letter to the editor

    • David Zogala
    • Václav Ptáčník
    • Martin Šámal

    Letter to the Editor 28 May 2022 Pages: 3334 - 3335

11. Response to letter to the editor

    • David Kersting
    • Miriam Sraieb
    • Christoph Rischpler

    Letter to the Editor Open access 09 July 2022 Pages: 3336 - 3339

    

12. A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

    • Marnix Lam
    • Etienne Garin
    • Riad Salem

    Original Article Open access 08 April 2022 Pages: 3340 - 3352

    

13. EANM guideline on quality risk management for radiopharmaceuticals

    • Nic Gillings
    • Olaug Hjelstuen
    • Almut Walte

    Guidelines Open access 07 April 2022 Pages: 3353 - 3364

    

14. [⁶⁸ Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease

    • Patrick Conen
    • Francesca Pennetta
    • Felix M. Mottaghy

    Original Article Open access 06 January 2022 Pages: 3365 - 3372

    

15. First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate

    • David Kersting
    • Miriam Sraieb
    • Christoph Rischpler

    Original Article Open access 12 April 2022 Pages: 3373 - 3386

    

16. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival

    • Francesco Fiz
    • Chiara Masci
    • Luca Viganò

    Original Article 26 March 2022 Pages: 3387 - 3400

    

17. The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT

    • Lavinia Monaco
    • Elisabetta De Bernardi
    • Luca Guerra

    Original Article 11 April 2022 Pages: 3401 - 3411

    

18. Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians

    • Elin Trägårdh
    • Olof Enqvist
    • Lars Edenbrandt

    Original Article Open access 27 April 2022 Pages: 3412 - 3418

    

19. Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [¹⁸F]FDG PET/CT study

    • Alberto Signore
    • Chiara Lauri
    • Antonio Aceti

    Original Article Open access 29 April 2022 Pages: 3419 - 3429

    

20. Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts

    • Chiara Lauri
    • Alberto Signore
    • Nabil Chakfé

    Guidelines Open access 04 April 2022 Pages: 3430 - 3451

    

21. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial

    • Elizabeth J. de Koster
    • Dennis Vriens
    • for the EfFECTS trial study group

    Original Article Open access 18 April 2022 Pages: 3452 - 3469

    

22. The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

    • Jingjia Cao
    • Xiaolu Zhu
    • Wei Zhang

    Original Article 02 May 2022 Pages: 3470 - 3481

    

23. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with ¹⁸F-SynVesT-1 positron emission tomography imaging

    • Yongxiang Tang
    • Jie Yu
    • Shuo Hu

    Original Article Open access 03 January 2022 Pages: 3482 - 3491

    

24. Quantitative assessment of myelin density using [¹¹C]MeDAS PET in patients with multiple sclerosis: a first-in-human study

    • Chris W. J. van der Weijden
    • Jan F. Meilof
    • Erik F. J. de Vries

    Original Article Open access 02 April 2022 Pages: 3492 - 3507

    

25. Quantification of amyloid PET for future clinical use: a state-of-the-art review

    • Hugh G. Pemberton
    • Lyduine E. Collij
    • on behalf of the AMYPAD consortium

    Review Article Open access 07 April 2022 Pages: 3508 - 3528

    

26. Efficacy and safety of ¹⁷⁷Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

    • Dominique Clement
    • Shaunak Navalkissoor
    • John Ramage

    Original Article Open access 07 April 2022 Pages: 3529 - 3537

    

27. Diagnostic performance of total-body ¹⁸F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT

    • Yan Hu
    • Guobing Liu
    • Hongcheng Shi

    Original Article 28 March 2022 Pages: 3538 - 3546

    

28. Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics

    • Seok Kim
    • Ji-In Bang
    • Ho-Young Lee

    Original Article 01 April 2022 Pages: 3547 - 3556

    

29. Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection

    • Pascal K. C. Jonker
    • Madelon J. H. Metman
    • Schelto Kruijff

    Original Article Open access 07 April 2022 Pages: 3557 - 3570

    

30. Feasibility of [⁶⁸Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma

    • Lena M. Unterrainer
    • Simon Lindner
    • Alexander Kretschmer

    Original Article Open access 24 March 2022 Pages: 3571 - 3580

    

31. Hematologic toxicity profile and efficacy of [²²⁵Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer

    • Ismaheel O. Lawal
    • Alfred Morgenstern
    • Mike M. Sathekge

    Original Article 06 April 2022 Pages: 3581 - 3592

    

32. First-time imaging of [⁸⁹Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner

    • Adrienne H. Brouwers
    • Joyce van Sluis
    • Charalampos Tsoumpas

    Image of the Month Open access 01 April 2022 Pages: 3593 - 3595

    

33. 225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma

    • Dengsai Peng
    • Hanxiang Liu
    • Yue Chen

    Image of the Month 06 May 2022 Pages: 3596 - 3597

    

34. Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients

    • David Wallis
    • Michaël Soussan
    • Irène Buvat

    Correction Open access 31 May 2022 Pages: 3598 - 3598